Today, we launched our patient registry and are accepting submissions from individuals with treatment-resistant depression (TRD) who may be interested in learning about potential future research opportunities. Sign up here 👉 registry.motifneuro.tech

The root cause for mental illness for many people is a circuit in the brain that's not acting the way it should. As engineers and scientists, who understand the circuits inside the brain, we can design the technologies to repair the circuits underlying the illness.

Big thank you to Advanced Research Projects Agency for Health (ARPA-H) for visiting Motif HQ. ARPA-H supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative health solutions for all.

Do you think the next moonshot is in mental health? We do. 🌝 Thanks to Astro Teller of X, the Moonshot Factory, for visiting @jacobrobinson.bsky.social lab at @riceneuro.bsky.social

Motif Neurotech CEO and Co-Founder @jacobrobinson.bsky.social will be speaking at the 2025 New York Brain-Computer Interface Symposium (NYBCI). Register at nybci.com Moderated by @bloomberg.com @ikeswetlitz.bsky.social

We always love @onemindorg.bsky.social Music Festival!! We're grateful to be a part of this mission-aligned community! #Music4BrainHealth @jacobrobinson.bsky.social

What I’m reading 👉📚 A powerful & personal piece by @jacobrobinson.bsky.social (CEO @motifneuro.bsky.social) on how brain-computer interfaces could transform mental health. Honest, bold & inspiring. I encourage folks to read & subscribe. brainjacob.substack.com #BCIs #BrainComputerInterface

Yesterday, we spent the day on Capitol Hill 🇺🇸 for the Rally for Medical Research. Jon Nelson joined our friends from @onemindorg.bsky.social to march and meet in support of making medical research a national priority.

Today is World Suicide Prevention. Motif stands with our community today to shine a light on suicide and because the silence and stigma in our society only increases the danger of this disease💡. Let's change the narrative so we can get well and stay well, together 🫂.

🇬🇧 Welcome and congrats to our first international employee, Sudam Dias! 🇬🇧 Based in London, Sudam will work closely with our partners at MintNeuro as we advance neural ASIC development through our collaboration with Advanced Research + Invention Agency (ARIA).

We’re thrilled to welcome Andrew Chen, MD, PhD to our team as a Senior Scientist! Andrew is a psychiatrist and will specialize in machine learning at Motif. He'll also work closely with our Community Advisory Board to integrate our lived experience experts into clinical efforts.

We all want to regulate our brain activity. Quite often we utilize substances and activities to try and achieve this even if they don't work very well or have negative side effects. We turn to antiquated solutions because they are safe and familiar 🧵

It’s a long road for someone suffering from severe mental illness. Antidepressants, TMS sessions at a clinic, ketamine, ECT. A plethora of antiquated options that leave patients still searching for relief. “How is this real?”

Our next #InterfaceNeuroGT session highlighted cutting-edge techniques for measuring and manipulating sensorimotor and cognitive behavior — across species and across scales. Sponsored by McCamish Parkinson's Disease Innovation Program and chaired by @drannabellesinger.bsky.social.

Last month, we had the privilege of being invited to share our advancements and our vision for the future of mental health care at the MARS conference.

Check out the view from Deep Tech Week NYC this week 🏙️ 😮‍💨. @jacobrobinson.bsky.social shared the stage with some great neurotech leaders for an evening of networking and industry collaboration. Shoutout to Psymed, Data Joint and Actual VC for hosting such a wonderful night!

Deeply grateful for my recent visits to @riceneuro.bsky.social, @bcmhouston.bsky.social, and @motifneuro.bsky.social! The passion for innovation and collaboration in the neuroscience research community is truly inspiring. Thanks for the opportunity to share the ongoing projects from our lab!

Our COO Nick Halper recently sat down with on Ones Changing the World Podcast 🔊 They discuss DOT - Motif's therapeutic neural device technology and our place in the broader brain-computer interfaces (#BCI) ecosystem. youtu.be/XqiiCWw1Cr0?...

Please join us in congratulating Julie Goode on her promotion to Vice President of Clinical Affairs! Julie will continue to lead our clinical research efforts as we prepare for clinical trials in 2025! 🚀

📽️ Check out @jacobrobinson.bsky.social on stage last month at CES 🚀 Jacob and the panel explore the potential of neural devices to help everyone live a better life 🧠 youtu.be/PKpDH3fjtxI?...

We're thrilled to welcome Joshua Woods, PhD as our Senior Electrical Engineer! Josh has already been integral in our work for years. His doctoral work at @jacobrobinson.bsky.social @riceuniversity.bsky.social included pioneering the first DOT and magnetoelectric power for neural networks.

We brought the whole team to Houston this week for our 2025 Strategy Summit. The team synergy is palpable and we're so excited for everything ahead of us this year 🧠 🛫

We're honored to be selected by @aria-research.bsky.social for a multimillion-dollar award through their Precision Neurotechnologies Program. This funding will accelerate the development of our therapeutic Brain-Computer Interface to treat mood, attention, and sleep disorders 🧠🚀

We've been selected by @aria-research.bsky.social to develop a network of neural devices designed to monitor and regulate mental and cognitive states without brain surgery. The UK-based program led by @jacquescarolan.bsky.social is contributing £69M to unlock the full potential of #neurotech.

We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)

Our Team got their groove on at the roller rink for the annual Motif holiday party! Wishing our team, advisors, investors, vendors, supporters and our industry a happy holiday season. Take extra care of yourselves and your loved ones these next few weeks.

Our Team got their groove on at the roller rink for the annual Motif holiday party! Wishing our team, advisors, investors, vendors, supporters and our industry a happy holiday season. Take extra care of yourselves and your loved ones these next few weeks.

At Motif, we’re building the world’s smallest implantable brain stimulator to engage the executive function network with a minimally invasive outpatient procedure lasting no more than 20 minutes. 🧠

Excited to welcome folks to the new @motifneuro.bsky.social , office, manufacturing, and R&D space at the TMC innovation building in Houston! The team is already hard at work building next-gen therapeutic BCIs... and eating cookies.

Today we're excited to unveil our new website and company video! We believe that people with difficult to treat mental health disorders deserve access to the most advanced therapies. That's why we're building therapeutic brain computer interfaces. 🔗⬇️ youtu.be/roZ3gOmuh9k?... www.motifneuro.tech

Here are some folks on the translational side of neurotech! Founders, engineers, translational labs, and investors. Please message me for folks I should add! go.bsky.app/N2LreWi